All In Biotech

Drug Trial Radar · NCT05597098

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women: RESOLVE-SEX

Last checked: Nov 19, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

34

Planned (sponsor's estimate)

Start

Dec 12, 2022

Primary completion

Dec 12, 2027

Study completion Dec 12, 2027

Sponsor

Lead sponsor
Queen Mary University of LondonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 27, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Important differences exist between sexes in incidence, disease patterns and outcomes in coronary artery disease that is not well understood. It is likely that key differences in the underlying biological mechanism, in particular in inflammatory responses, play a part in underpinning these differences. Previous evidence demonstrates that healthy females appear to be more adept at resolving inflammation compared to healthy males. Since inflammation is thought to be a key initiating phenomenon in coronary artery disease the investigators will examine the differences in inflammatory resolution between the sexes in healthy volunteers.

Conditions

  • Inflammation

Interventions

  • CantharidinDrug

    0.1% cantharidin solution in acetone from 0.7% stock solution of cantharone is prepared and applied immediately. 10 μl of cantharidin per disc.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of the presence or not of blister at each timepoint over 24-72h between the sexesTime frame: 24 hours, 48 hours, 72 hours
  2. Comparison of blister volume at each timepoint over 24-72h between the sexesTime frame: 24 hours, 48 hours, 72 hours
  3. Comparison of blister cell number at each timepoint over 24-72 hours between the sexesTime frame: 24 hours, 48 hours, 72 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The William Harvey Research Institute

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.